Lars Anders

Lars Anders is a Scientific Director at Pfizer with over 10 years of experience in pharmaceutical drug development, particularly in oncology. They earned a PhD in Cancer Biology from the Max-Planck Institute for Biochemistry and have held roles such as Postdoctoral Scientist at both Harvard Medical School and MIT. At Pfizer, Lars leads a cell cycle group and has overseen the development of significant cancer therapies like Atirmociclib and Tegtociclib. They are dedicated to advancing therapeutic modalities that aim to cure cancer and enhance human health.